New vaccine is cheap for Africa
Europe's largest pharmaceutical company GSK has announced the production of cheap vaccines for African countries: Globorix vaccine helps prevent meningitis.
Europe's largest pharmaceutical company GSK has announced the production of cheap vaccines for African countries: Globorix vaccine helps prevent meningitis.
Children are particularly at risk of meningitis (Photo: AFP)
The price of this vaccine may not be enough to cover research costs: over $ 400 million, and only sold and used in Africa alone.
Globorix aims to prevent meningitis A and C with more efficacy than the old vaccine called Titanrix, which helps prevent diphtheria, tetanus, coughing on the day, Haemophilus influenzae - the culprit causing meningitis.
According to experts, this is a sign that big companies are changing business habits, but some commentators think that is not enough. The GSK said that this action is not a " way " of their new business, nor a form of PR.
Millions of people in Africa are at high risk of meningitis, which can kill a child within 6 hours.
T.VY
- The world's first vaccine against malaria is put into use in Africa
- MVA85A: New vaccine against TB
- Canada will donate the Ebola vaccine to WHO
- There will soon be a new vaccine against TB
- The anti-Ebola vaccine is about to be tested on a large scale
- New vaccine to prevent meningitis
- Test of new malaria vaccine in Africa
- Italy will test the HIV / AIDS vaccine in South Africa
- Successfully tested Ebola vaccine
- New hope in the fight against Ebola virus
Green tea cleans teeth better than mouthwash? Death kiss: This is why you should not let anyone kiss your baby's lips What is salmonellosis? Caution should be exercised when using aloe vera through eating and drinking Prospects gel to help women fight HIV 'Glass' Female is XX, male is XY, but why not have YY chromosome? Cure male infertility with artificial sperm